Provectus Biopharmaceuticals Inc.

354 articles about Provectus Biopharmaceuticals Inc.

• Provectus Pharmaceuticals Inc. Receives Patent Protection Notice From European Patent Office

  9/12/2007

• Provectus Pharmaceuticals Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma

  9/5/2007

• Provectus Pharmaceuticals Inc. Releases Video of Provecta(TM) in Action on Human Patient

  5/21/2007

• Provectus Pharmaceuticals Inc. Completes Dosing of Patients in Phase 1 Melanoma Study

  4/24/2007

• Provectus Pharmaceuticals Inc. Comments on 2006 Fourth Quarter and Year to Date Milestones

  3/26/2007

• Provectus Pharmaceuticals Inc. Retains The Investor Relations Group of New York

  3/13/2007

• Provectus Pharmaceuticals Inc. To Receive Patent For Novel Acne Product

  2/21/2007

• Provectus Pharmaceuticals Inc. Receives Orphan Drug Designation From FDA For Anti-Cancer Agent PV-10 For The Treatment Of Metastatic Melanoma

  1/8/2007

• Provectus Pharmaceuticals Inc. To Appear On MN1.com

  12/19/2006

• Provectus Pharmaceuticals Inc. Receives Patent Protection Notices In Europe And Taiwan

  12/13/2006

• Provectus Pharmaceuticals Inc. To Present At The NYSSA 2006 Biotech & Specialty Pharmaceuticals Industry Conference In New York City

  12/5/2006

• Provectus Pharmaceuticals Inc. Comments On 2006 Third Quarter Results

  11/14/2006

• Provectus Pharmaceuticals Inc. CEO To Speak At Melanoma Research Foundation Board Meeting

  10/3/2006

• Leading Melanoma Specialist Validates Ablative Ability And Systemic Effects Of Provectus Pharmaceuticals Inc. Anti-Cancer Agent PV-10

  9/14/2006

• Provectus Pharmaceuticals Inc. Melanoma Investigator Validates Therapeutic Use Of PV-10

  8/17/2006

• Provectus Pharmaceuticals Inc. CEO To Present At Annual Meeting Of The American Society For Photobiology

  6/20/2006

• Provectus Pharmaceuticals Inc. CEO Issues Open Letter To Shareholders

  6/1/2006

• Provectus Pharmaceuticals Inc. Completes Initial Phase 1 Metastatic Melanoma Clinical Trial Objectives

  5/15/2006

• Provectus Pharmaceuticals Inc. Comments On 2006 First Quarter Results

  5/15/2006

• Provectus Pharmaceuticals Inc. To Present At Upcoming Investment Community Events

  5/3/2006